Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Johnson & Johnson told to throw out 60M COVID-19 shots made at troubled Emergent site: report
‘Place them in the trash’: FDA warns against using Innova’s rapid COVID-19 antigen tests
GSK reveals 26 million Americans skipped routine vaccinations last year, quantifying widely held suspicions
HHS gives providers flexibility on spending COVID-19 relief funds, updates reporting requirements
COVID-19 tracker: EU doesn't expect J&J to reach June vaccine delivery goal as U.S. scraps millions of doses
HHS to give $424M to rural health clinics for COVID-19 tests, mitigation strategies
Oxford spinout spies the hidden mechanics of DNA and disease with single-pair resolution method
Lilly's internal probe into Branchburg, New Jersey, plant found company didn't mislead FDA, but DOJ investigation remains: report

Featured Story

Johnson & Johnson told to throw out 60M COVID-19 shots made at troubled Emergent site: report

By Noah Higgins-Dunn

The FDA has instructed Johnson & Johnson to toss about 60 million COVID-19 vaccines made at Emergent BioSolutions' troubled factory in Baltimore, Maryland, the New York Times reports.

‘Place them in the trash’: FDA warns against using Innova’s rapid COVID-19 antigen tests

By Conor Hale

The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. for hundreds of millions of kits.

GSK reveals 26 million Americans skipped routine vaccinations last year, quantifying widely held suspicions

By Beth Snyder Bulik

More than 26 million Americans skipped doses of standard recommended vaccines in 2020, according to GlaxoSmithKline. That's 8.8 million adolescents and 17.2 million adults who missed vaccines between January and November, discovered through claims analysis by Avalere Health commissioned by GSK.

HHS gives providers flexibility on spending COVID-19 relief funds, updates reporting requirements

By Robert King

HHS gave providers flexibility on a key June 30 deadline to spend all their COVID-19 relief funds, giving recipients more time to use the funds if they were received after June 30, 2020.

COVID-19 tracker: EU doesn't expect J&J to reach June vaccine delivery goal as U.S. scraps millions of doses

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

The European Union no longer expects Johnson & Johnson to reach its goal of delivering 55 million vaccines to the bloc by the end of June. Meanwhile, U.S. regulators told the company to scrap about 60 million doses after the production mishap at the troubled Emergent plant. And more headlines.

HHS to give $424M to rural health clinics for COVID-19 tests, mitigation strategies

By Robert King

HHS is giving rural health clinics $424.7 million to increase their supplies of COVID-19 tests and to boost strategies to mitigate the virus.

Oxford spinout spies the hidden mechanics of DNA and disease with single-pair resolution method

By Conor Hale

Nucleome Therapeutics has found a new way to depict and analyze DNA with super-fine resolution, allowing them to peer into “the dark matter of the human genome” and the molecular basis of many diseases. What they hope to find are answers about COVID-19 severity—and new drug targets for multiple sclerosis and rheumatoid arthritis.

Lilly's internal probe into Branchburg, New Jersey, plant found company didn't mislead FDA, but DOJ investigation remains: report